CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 47,378	$ 81,787
Research and development incentive receivable	843	747
Prepaid expenses and other current assets	4,364	5,344
Total current assets	52,585	87,878
Property and equipment, net	1,309	1,514
Goodwill	17,351	17,351
Right-of-use assets	7,976	8,710
Other assets	1,798	1,723
Total assets	81,019	117,176
Current liabilities:
Accounts payable	3,677	4,283
Accrued expenses	8,582	7,870
Current portion of lease liability	1,136	1,075
Current portion of long-term debt	8,607	795
Total current liabilities	22,002	14,023
Long-term debt, net of discount and current portion	24,490	33,139
Lease liabilities	4,140	4,776
Other liabilities	314	826
Total liabilities	50,946	52,764
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 shares authorized as of each of June 30, 2022 and December 31, 2021; 30,991,198 and 28,127,657 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	31	28
Additional paid-in capital	356,209	347,374
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(326,048)	(282,871)
Total stockholders’ equity	30,073	64,412
Total liabilities and stockholders’ equity	$ 81,019	$ 117,176